The Korean Journal of Physiology and Pharmacology

  • 제7권2호
  • /
  • Pages.103-109
  • /
  • 2003
  • /
  • 1226-4512(pISSN)
  • /
  • 2093-3827(eISSN)
대한약리학회 (The Korean Society of Pharmacology)
권호 표지

Involvement of NAD(P)H Oxidase in a Potential Link between Diabetes and Vascular Smooth Muscle Cell Proliferation

  • Jeong, Hye-Young (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Yun, Mi-Ran (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Kim, Chi-Dae (Department of Pharmacology, College of Medicine, Pusan National University)
  • 발행 : 2003.04.21
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The cellular mechanisms that contribute to the acceleration of atherosclerosis in diabetes are poorly understood. Therefore, the potential mechanisms involved in the diabetes-dependent increase in vascular smooth muscle cell (VSMC) proliferation was investigated. Using primary culture of VSMC from streptozotocin-induced diabetic rat aorta, cell proliferation assay showed two-fold increase in cell number accompanied with enhanced superoxide generation compared to normal VSMC, 2 days after plating. Both the increased superoxide production and cell proliferation in diabetic VSMC were significantly attenuated by not only tiron (1 mM), a superoxide scavenger, but also by diphenyleneiodonium (DPI; $10{\mu}M$), an NAD(P)H oxidase inhibitor. NAD(P)H oxidase activity in diabetic VSMC was significantly higher than that in control cell, accompanied with increased mRNA expression of p22phox, a membrane subunit of oxidase. Furthermore, inhibition of p22phox expression by transfection of antisense p22phox oligonucleotides into diabetic VSMC resulted in a decrease in superoxide production, which was accompanied by a significant inhibition of cell proliferation. Based on these results, it is suggested that diabetes-associated increase in NAD(P)H oxidase activity via enhanced expression of p22phox contributes to augmented VSMC proliferation in diabetic rats.

키워드

참고문헌

  1. Absher P, Schneider D, Baldor L, Russell J, Sobel B. The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Atherosclerosis 143: 245-251, 1999 https://doi.org/10.1016/S0021-9150(98)00295-0
  2. Bayraktutan U, Draper N, Lang D, Shah AM. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res 38: 256 -262, 1998 https://doi.org/10.1016/S0008-6363(98)00003-0
  3. Bern MM. Platelet functions in diabetes mellitus. Diabetes 27: 42- 50, 1978 https://doi.org/10.2337/diabetes.27.1.42
  4. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988 https://doi.org/10.1056/NEJM198805193182007
  5. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86: 391-395, 2000 https://doi.org/10.1161/01.RES.86.4.391
  6. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetes in the Framingham population. Sixteenyear follow-up study. Diabetes 23: 105-111, 1974 https://doi.org/10.2337/diab.23.2.105
  7. Giugliano D, Periello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996 https://doi.org/10.2337/diacare.19.3.257
  8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141- 1148, 1994 https://doi.org/10.1161/01.RES.74.6.1141
  9. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 96: 3264-3265, 1997
  10. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J, Hoyt RF, Holland SM, Finkel T. Vascular effects following homozygous disruption of p47(phox): an essential component of NADPH oxidase. Circulation 101: 1234-1236, 2000 https://doi.org/10.1161/01.CIR.101.11.1234
  11. Inoguchi T, Li P, Umeda F, Yu HK, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000 https://doi.org/10.2337/diabetes.49.11.1939
  12. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97: 135-137, 1998 https://doi.org/10.1161/01.CIR.97.2.135
  13. Kannel WB, Catelli WP, Gordon T, Macnamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 74: 1-12, 1971 https://doi.org/10.7326/0003-4819-74-1-1
  14. Kannel WB, McGree DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038, 1979 https://doi.org/10.1001/jama.241.19.2035
  15. Karasu C Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 46: 872-879, 1997 https://doi.org/10.1016/S0026-0495(97)90072-X
  16. Karasu C. Time course of changes in endothelium-dependent and-independent relaxation of chronically diabetic aorta: role of reactive oxygen species. Eur J Pharmacol 392: 163-173, 2000 https://doi.org/10.1016/S0014-2999(00)00140-0
  17. Karin E, Bornfeldt. Intracellular signaling in arterial smooth muscle migration versus proliferation. Trends Cardiovasc Med 6: 143-151, 1996 https://doi.org/10.1016/1050-1738(96)00038-2
  18. Kawano M, Koshikawa T, Kanzaki T, Morisaki N, Saito Y, Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF betareceptors. Eur J Clin Invest 23: 84-90, 1993 https://doi.org/10.1111/j.1365-2362.1993.tb00745.x
  19. Kim YK, Lee MS, Son SM, Kim IJ, Lee WS, Rhim BY, Hong KW, Kim CD. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51: 522-527, 2002 https://doi.org/10.2337/diabetes.51.2.522
  20. Kimura I, Nagamori A, Honda R, Kobayashi S. Glycated serum stimulation of macrophages in GK- and streptozotocin-rats for the proliferation of primary cultured smooth muscle cells of the aorta. Immunopharmacology 40: 105-118, 1998 https://doi.org/10.1016/S0162-3109(98)00024-1
  21. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999 https://doi.org/10.1016/S0008-6363(99)00169-8
  22. Larson DM, Haudenschild CC. Activation of smooth muscle cell outgrowth from BB/Wor rat aortas. Diabetes 37: 1380-1385, 1988 https://doi.org/10.2337/diabetes.37.10.1380
  23. Lee JS, Kypreos KE, Sonenshein GE. Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine. Exp Cell Res 2: 447-453, 1998
  24. Majander A, Finel M, Wikstrom M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADHubiquinone oxidoreductase (Complex I). J Biol Chem 269: 21037 -21042, 1994
  25. Melton LJ 3rd, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 3: 650-654, 1980 https://doi.org/10.2337/diacare.3.6.650
  26. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266: H2568-H2572, 1994
  27. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995
  28. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791- 804, 1995 https://doi.org/10.1146/annurev.ph.57.030195.004043
  29. Stout RW. Insulin-stimulated lipogenesis in arterial tissue in relation to diabetes and atheroma. Lancet 2: 702-703, 1968
  30. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 100: 1494-1498, 1999
  31. Ushio-Fukai M, Zafari M, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996 https://doi.org/10.1074/jbc.271.38.23317
  32. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998 https://doi.org/10.1073/pnas.95.16.9220
  33. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Bohm M, Meinnertz T, Munzel T. Increased NADH-oxidasemediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99: 2027-2033, 1999 https://doi.org/10.1161/01.CIR.99.15.2027
  34. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 93: 8745 -8749, 1996 https://doi.org/10.1073/pnas.93.16.8745